Photoaffinity labeling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes

Molecular and Biochemical Parasitology

Volumn 82, Issue 2, 1996, Pages 181-194

  Desneves, José ^a   Thorn, Gabrielle ^a   Berman, Ann ^a   Galatis, Denise ^c   La Greca, Nadia ^a   Sinding, Jens ^b   Foley, Michael ^a   Deady, Leslie W ^a   Cowman, Alan F ^c   Tilley, Leann ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b AARHUS UNIVERSITY   (Denmark)

^c NONE

Author keywords

Apo A1; Band 7.2b; Malaria; Mefloquine; Photoaffinity labeling; Quinoline antimalarials

Indexed keywords

ANTIMALARIAL AGENT; DRUG BINDING PROTEIN; MEFLOQUINE; QUINOLINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; MALARIA; NONHUMAN; PHOTOAFFINITY LABELING; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

PLASMODIUM FALCIPARUM;

EID: 0030602239     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-6851(96)02732-6     Document Type: Article

References (43)

1. [1] Geary, T.G., Bonanni, L.C., Jensen, J.B. and Ginsburg, H. (1986) Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture. Ann. Trop. Med. Parasitol. 80, 285-291.
2. [2] Fitch, C.D., Yunis, N.G., Chevli, R. and Gonzales, Y. (1974) High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. J. Clin. Invest. 54, 24-33.
3. [3] Slater, A.F.G. and Cerami, A. (1992) Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355, 167-269.
4. [4] Dorn, A., Stoffel, R., Matile, H., Bubendorf, A. and Ridely, R.G. (1995) Malarial haemozoin/β-haematin supports haem polymerisation in the absence of protein. Nature 374, 269-271.
5. [5] Ginsburg, H., Nissani, E. and Krugliak, M. (1989) Alkalinisation of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem. Pharmacol. 38, 2645-2654.
6. [6] Schmidt, L.H., Crosby, R., Rasco, J. and Vaughan, D. (1978) Antimalarial activities of various 4-quinolinemethanols with special attention to WR-142490 (mefloquine). Antimicrob. Agents Chemother. 13, 1011-1030.
7. [7] Geary, T.G. and Jensen, J.B. (1983) Lack of cross-resistance to 4-aminoquinolines in chloroquine-resistant Plasmodium falciparum in vitro. Biochem. Pharmacol. 43, 63-70.
8. [8] Vanderkooi, G., Prapunwattana, P. and Yuthavong, Y. (1988) Evidence for electrogenic accumulation of mefloquine by malarial parasites. Biochem. Pharmacol. 37, 3623-3631.
9. [9] Chou, A.C. and Fitch, C.D. (1993) Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem. Biophys. Res. Commun. 195, 422-428.
10. [10] San George, R.C., Nagel, R.L. and Farby, M.E. (1984) On the mechanism of the red-cell accumulation of mefloquine, an antimalarial drug. Biochim. Biophys. Acta 803, 174-181.
11. [11] Mu, J.Y., Israili, Z.H. and Dayton, P.G. (1975) Studies of the disposition and metabolism of mefloquine HC1 (WR 142490), a quinolinemethanol antimalarial, in the rat. Drug Metab. Dispos. 3, 198-210.
12. [12] Fitch, C.D., Chan, R.L. and Chevli, R. (1979) Chloroquine resistance in malaria: accessibility of drug receptors to mefloquine. Antimicrob. Agents Chemother. 15, 258-262.
13. [13] White, N.J. (1994) Mefloquine in the prophylaxis and treatment of falciparum malaria. Br. Med. J. 308, 286-287.
14. [14] Wilson, C.M., Volkman, S.K., Thaithong, S., Martin, R.K., Kyle, D.E., Milhous, W.K. and Wirth, D.F. (1993) Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in P. falciparum from Thailand. Mol. Biochem. Parasitol. 57, 151-160.
15. [15] Cowman, A.F., Galatis, D. and Thompson, J.K. (1994) Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA, 91, 1143-1147.
16. [16] Wilson, C.M., Serrano, A.E., Wasley, A., Bogenschutz, M.P., Shankar, A.H. and Wirth, D.F. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244, 1184-1186.
17. [17] Deady, L.W. and Desneves, J. (1995) An improved procedure for the preparation of aryloxiranes. Org. Prep. Proc. Intl. 27, 219-221.
18. [18] Husain, S.N., Gentile, B., Sauers, R.R. and Eichholz, A. (1983) Synthesis of photoaffinity labeling derivatives of D-glucose and D-galactose. Carbohydr. Res., 118, 57-63.
19. [19] Trager, W. and Jensen, J.B. (1976) Human malaria parasites in continuous culture. Science 193, 673-675.
20. [20] Foote, S.J., Thompson, J.K., Cowman, A.F. and Kemp. D.J. (1989) Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57, 921-930.
21. [21] Barnes, D.A., Foote, S.J., Galatis, D., Kemp, D.J. and Cowman, A.F. (1992) Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. EMBO J. 11, 3067-3075.
22. [22] Aley, S.B., Sherwood, T.A., Marsh, D., Eidelman, O. and Howard, R.J. (1986) Identification of isolate-specific proteins on sorbitol-enriched Plasmodium falciparum-infected erythrocytes from Gambian patients. Parasitology, 92, 511-525.
23. [23] Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 682-685.
24. [24] Tetaz, T., Bozas, E., Kanellos, J., Walker, I. and Smith, I. (1993). In: Techniques in Protein Chemistry (Hogue Angletti, ed;), Vol. IV, pp. 389-397. Academic Press, USA.
25. [25] Karcz, S.R., Galatis, D. and Cowman, A.F. (1993) Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. Mol. Biochem. Parasitol. 58, 269-276.
26. 3 with receptors on cultured cells. J. Biol. Chem. 260, 3570-3575.
27. [27] Hiebl-Dirschmied, C.M., Entler, B., Glotzmann, C., Maurer-Fogy, I., Stratowa, C. and Prohaska, R. (1991) Cloning and nucleotide sequence of cDNA encoding human erythrocyte band 7 integral membrane protein. Biochim. Biophys. Acta 1090, 123-124.
28. [28] Lutz, R.E., Bailey, P.S., Clark, M.T., Codington, J.F., Deinet, A.J., Freek, J.A., Harnest, G.H., Leake, N.H., Martin, T.A., Rowlett, R.J., Salsbury, J.M., Shearer, N.H., Smith, J.D. and Wilson, J.W. (1946) α-Alkyl and dialkylaminomethyl-2-phenyl-4-quinolinemethanols. J. Am. Chem. Soc. 68, 1813-1831.
29. [29] Duncan, W.G., Colwell, W.T., Scott, C. R. and Henry, D.W. (1968) Arylamino alcohol antimalarials. A new method for incorporating the side chain. J. Med. Chem. 11, 1221-1223.
30. [30] Johnson, O.H. and Hamilton, C. S. (1941) Synthesis in the quinoline series. II. Some derivatives of 4-methylquinoline and a study of their structures. J. Am. Chem. Soc. 63, 2864-2867.
31. [31] Buchman, E.R., McLoskey, C.M. and Seneker, J.A. (1947) 8-Nitrocinchoninic acids and related substances. J. Am. Chem. Soc. 69, 380-384.
32. [32] Haley, B. E. (1991) Nucleotide photoaffinity labelling of protein kinase subunits. Methods Enzymol. 200, 477-457.
33. [33] Kara, U.A.K., Stenzel, D.J., Ingram, L.T., Bushell, G.R., Lopez, J.A. and Kidson, C. (1988) Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane. Infect. Immun. 56, 903-909.
34. [34] Kruigliak, M. and Ginsburg, H. (1991) Studies on the antimalarial mode of action of quinoline-containing drugs: time-dependence and irreversibility of drug action, and interactions with compounds that alter the function of the parasite's food vacuole. Life Sci. 49, 1213-1219.
35. [35] Foley, M., Deady, L.W., Ng, K., Cowman, A.F. and Tilley, L. (1994) Photoaffinity labelling of chloroquine-binding proteins in Plasmodium falciparum. J. Biol. Chem. 269, 6955-6961.
36. [36] Kim, K.H., Hansch, C., Fukunaga, J.Y., Steller, E.E., Jow, P.Y.C., Craig, P.N. and Page, J. (1979) Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarials. J. Med. Chem., 22, 366-391.
37. [37] Cenni, B., Meyer, J., Brandt, R. and Betschart, B. (1995) The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum. Br. J. Clin. Pharmacol. 39, 519-526.
38. [38] Grellier, P., Rigomier, D., Clavey, V., Fruchart, J-C. and Schrevel, J. (1991) Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells. J. Cell Biol. 112, 267-277.
39. [39] Desneves, J., Berman, A., Dynon, K., La Greca, N., Foley, M. and Tilley, L. (1996) Human erythrocyte band 7.2b is preferentially labelled by a photoreactive phospholipid. Biochem. Biophys. Res. Commun. 224, 108-114.
40. [40] Schwartz, D.E., Eckert, G., Hartmann, D., Weber, B., Richard-Lenoble, D., Ekue, J.M.K. and Gentilini, M. (1982) Single dose kinetics of mefloquine in man. Chemotherapy 28, 70-84.
41. [41] ter Kuile, F.O., Nosten, F., Thieren, M., Luxemburgerer, C., Edestein, M.D., Chongsuphajaisiddhi, T., Phaipun, L., Webster, H.K. and White, N.J. (1992) High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J. Infect. Dis. 166, 1393-1400.
42. [42] Polet, H. and Barr, C.F. (1968) Chloroquine and dihydroquinine. In vitro studies of their antimalarial effect upon Plasmodium knowlesi. J. Pharmacol. Exp. Ther. 164, 380-386.
43. [43] Berman, A., Shearing, L., Ng, K., Jinsart, W., Foley, M. and Tilley, L. (1994) Photoaffinity labelling of Plasmodium falciparum proteins involved in phospholipid transport. Mol. Biochem. Parasitol. 67, 235-243.